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Abstract
Staphylococcus warneri, similarly to other coagulase-negatine Staphy-
lococcus (CoNS), is a commensal of the skin, mucous membranes, 
nasal cavities and mouth of humans, found in 50% of the population. 
This species usually represents less than 1% of the total staphylococ-
cal skin population. S. warneri can potentially cause severe infections 
usually in immunocompromised individuals, even more in combina-
tion with the presence of indwelling devices and/or implants. The key 
treatment for such infections is the removal of the device. Sometimes, 
even in the absence of a foreign body, Staphylococcus warneri may be 
implicated as the causative agent of an infection in immunocompetent 
patients. We report here a case of chronic urinary tract infection  in 
adult healthy patient caused by S.warneri, its clinical significance and 
resistant to commonly used beta-lactams .
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Introduction
Urinary tract infections (UTI) remain one of the 
most prevalent and frustrating morbidities for neu-
rogenic bladder patients. Risk factors include uri-
nary stasis, high bladder pressures, bladder stones, 
and catheter use. While classic symptoms of UTI 
include dysuria, increased frequency and urgency, 
neurogenic bladder patients present differently with 
increased spasticity, urinary incontinence, and vague 
pains. Escherichia coli is the most common isolated 
pathogen, followed by Klebsiella pneumonia, En-
terococcus faecalis, Proteus mirabilisand  Pseudo-
mona saeruginosa [1].
Most clinical isolates of CoNS were mostly suscep-
tible to penicillins few decades ago.
Here we present a rare case of urinary tract infec-
tion caused by Staphylococcus warneri.
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Case presentation
A female patient of Greek origin, 36years old, came 
in for outpatient urine culture due to symptoms 
from the lower urinary tract. The patient had suf-
fered surgery five years ago for spinal fusion, which 
caused damage to the spinal cord and resulting in 
the development of neurogenic bladder. Since then 
she is catheterized daily with disposable catheters 
and often presented urinary tract infection (UTI) 
caused by E. coli. Urine culture was inoculated onto 
MacConkey 2 and Blood agar (bioMérieux). The 
plates were incubated at 370C under aerobic condi-
tions for 24-48h. After a 24-hour incubation period, 
large, white, non-haemolytic, smooth colonies with 
concentration 104cfu/ml were seen on blood agar, 
whereas no growth was observed on MacConkey 
2. Gram staining revealed the presence of gram (+), 
catalase (+), coagulase (-) cocci arranged in tetrads. 
Identification and susceptibility testing were per-
formed by the Vitek 2 system (bioMérieux). Staphy-
lococcus warneri was identified. The strain showed 
resistance only to beta-lactams.
Discussion
The frequent use of indwelling devices and implants 
as well as the increase number of immunocompro-
mised patients have given rise to infections caused 
by organisms which are otherwise considered to be 
contaminates. S. warneri belongs to the group of 
CoNS which also includes the following species iso-
lated from human clinical specimens: S. epidermidis, 
S. haemolyticus, S. saprophyticus, S. lugdunensis, S. 
hominis, S. simulans, S. capitis, S. auricularis, S. coh-
nii, S. caprae and S. Pasteur.They colonize the skin 
and mucosa of human and can cause severe infec-
tions, mainly in hospitalized patients. They are also 
common contaminants of cultures, and they are 
able to produce biofilms on the surface of various 
materials, some of them of medical importance [2]. 
Staphylococcus warneri has been found to be re-
sponsible for catheter-related bacteremia, native 
and prosthetic valve endocarditis (PVE), hematog-
enous vertebral osteomyelitis, ventriculoperitoneal 
shunt-associated meningitis, spondylodiscitis, septic 
arthritis, prostatitis and  meningitis in a patient with 
Strongyloides stercoralis [3-5]. According to the lit-
erature, the cases of urinary tract infections caused 
by S. warneriare extremely rare. 
Our patient was a healthy adult, except that she was 
catheterised daily in order to void her urine bladder. 
This fact confirms the association between indwell-
ing devices and CoNS reported in the literature [2, 
6, 7, 9].
In our case the isolate was susceptible to quinolones, 
nitrofurantoin, sulfamethoxazole/trimethoprim, line-
zolid, aminoglycosides, teicoplanin and vancomycin 
but resistant to beta-lactams. These findings corre-
late with the results of the research of Marrie and 
Kwan [6], who tested the susceptibility of 8 strains 
S.warneri from urine specimen. The isolates were 
resistant to ampicillin and cephalexin and suscepti-
ble to nitrofurantoin and nalidic acid similarly to our. 
In another multicenter study that was conducted in 
12 hospitals in China, urine samples were collected 
from 356 symptomatic patients treated for acute 
uncomplicated cystitis, recurrent UTI or complicated 
UTI. The most frequently identified Gram-positive 
pathogens were Stahylococcus coagulase negative 
spp. (17.1%). Sensitivity rates were 38.5% to oxa-
cillin, 50% for levofloxacin, and 100% for nitro-
furantoin [7]. In a recent study (8) a total of 185 
clinically- significant CoNS isolates were collected in 
a department of microbiology from various samples 
as follows: 85 were from blood culture, 36 from 
urine samples, 29 from pus, 14 from vaginal swab 
and 21 from miscellaneous group (drains, catheter, 
and fluids). Result of antibiotic susceptibility testing 
showed 100% sensitivity to vancomycin. Sensitivity 
to other antibiotic were as follow: amikacin 61.6%, 
ciprofloaxcin 35.1%, nalidixic acid 35.1%, gentami-
cin 33.5%, cefotaxime 31.8%, cefepime 33.5%, co-
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trimaxozocle 26.4%, erythromycin 30.27%, penicil-
lin G 9.72% and methicillin (34.5%).  In the cases of 
CoNS infections reported so far, the microorganisms 
were found to be at high rates methicillin-resistant, 
more specifically to ampicillin, amoxy/clav and the 
cephalosporins, whereas resistance rates to linezolid, 
vancomycin and teicoplanin was low. Sensitivity to 
quinolones, sulfamethoxazole/trimethoprim, nitro-
furantoin and aminoglycosides vary among studies 
[8,9]. However, a recent paper  from Germany has 
reported increased incidence of linezolid-resistance 
S. epidermidis isolates from hospitalized patient [10]
Conclusion
Because CoNS are ubiquitous especially skin coloniz-
ers, they are frequently found as contaminants in 
clinical specimens, a fact that complicates laborato-
ry interpretation of their clinical significance. When 
these organisms are isolated in routine laboratory 
in not significant numbers (counts ≤ 105cfu/ml ), 
every effort should be made to substantiate their 
clinical relevance and antimicrobial susceptibility in 
each case so that the an effective antibiotic can be 
used in the treatment.
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